The estrogen signalling pathway leads to the over-expression of Estrogen receptors (ESR1 and ESR2), and the over-expression of Progesterone receptors (PGR) genes are involved in luminal A breast cancer. The gene discussed is ESR1; the disease is breast carcinoma.